Trials that use: Covariate adjustment
5,848 results
- NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b): Complete Statistical AnalysisIndependent statistical analysis of NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b): primary endpoint results, effect estimate with…
- NMDA Antagonists in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of NMDA Antagonists in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01833897).
- NO-ASPIRATEIndependent statistical analysis of Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02284178).
- no-cryIndependent statistical analysis of Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- No-POPPYIndependent statistical analysis of Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NOH303Independent statistical analysis of Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NOHARMIndependent statistical analysis of Novel Use Of Hydroxyurea in an African Region With Malaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01976416).
- NOLANIndependent statistical analysis of NOLAN: Naproxen or Loratadine and Neulasta: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01712009).
- NOM-ERAIndependent statistical analysis of Non-Operative Management and Early Response Assessment in Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03904043).
- Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events: Complete Statistical AnalysisIndependent statistical analysis of Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03183063).
- Non-DrinkerIndependent statistical analysis of Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma: primary endpoint…
- Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders: Complete Statistical AnalysisIndependent statistical analysis of Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure: Complete Statistical AnalysisIndependent statistical analysis of Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01680783).
- Non-Pharmacological Interventions on Sleep in Post-Acute Rehabilitation: Complete Statistical AnalysisIndependent statistical analysis of Non-Pharmacological Interventions on Sleep in Post-Acute Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00333619).
- Non-Pharmacological Treatments for Insomnia in Chronic Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Non-Pharmacological Treatments for Insomnia in Chronic Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03261674).
- Noninvasive Modulation of Motivational Brain Regions in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Noninvasive Modulation of Motivational Brain Regions in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04972786).
- Normobaric Hyperoxia for Intracerebral Hemorrhage: Complete Statistical AnalysisIndependent statistical analysis of Normobaric Hyperoxia for Intracerebral Hemorrhage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04144868).
- Norovirus Bivalent-Vaccine Efficacy Study: Complete Statistical AnalysisIndependent statistical analysis of Norovirus Bivalent-Vaccine Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01609257).
- NOSE-400Independent statistical analysis of A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NOTUSIndependent statistical analysis of the phase 3 NOTUS trial of dupilumab versus placebo in moderate to severe COPD with type 2 inflammation: negative binomial exacerbation-rate analysis, MMRM lung-function and SGRQ results, hierarchical…
- Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action: Complete Statistical AnalysisIndependent statistical analysis of Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04271202).
- Novel Management of Airway Protection in Parkinson’s Disease: A Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Novel Pharyngeal Metrics to Predict Dysphagia Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Novel Pharyngeal Metrics to Predict Dysphagia Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04569097).
- NOVEMBERIndependent statistical analysis of Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- nPower™-USIndependent statistical analysis of Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies: Complete Statistical AnalysisIndependent statistical analysis of NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NPWTCSIndependent statistical analysis of Negative Pressure Wound Therapy in Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02289157).
- NSAID Use in Postpartum Hypertensive Women: Complete Statistical AnalysisIndependent statistical analysis of NSAID Use in Postpartum Hypertensive Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02902172).
- NSCLCIndependent statistical analysis of Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: Complete Statistical AnalysisIndependent statistical analysis of NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours: Complete Statistical AnalysisIndependent statistical analysis of NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NUDGE-EHRIndependent statistical analysis of NUDGE-EHR Replication Trial at Mass General Brigham: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05538065).
- Nudges and Incentives to Enhance the Opioid Treatment Workforce: Complete Statistical AnalysisIndependent statistical analysis of Nudges and Incentives to Enhance the Opioid Treatment Workforce: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03834025).
- NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study: Complete Statistical AnalysisIndependent statistical analysis of NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669785).
- Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT: Complete Statistical AnalysisIndependent statistical analysis of Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT: primary endpoint results, effect estimate with confidence interval, sample-size…
- Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab: Complete Statistical AnalysisIndependent statistical analysis of Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01435265).
- Nutraceutical Efficacy for rUTI: Complete Statistical AnalysisIndependent statistical analysis of Nutraceutical Efficacy for rUTI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395288).
- O-BMTIndependent statistical analysis of Onsite Buprenorphine Treatment at Syringe Exchange Programs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03150173).
- OAKTREEComplete statistical analysis of the randomized phase 3 OAKTREE trial of obeldesivir in nonhospitalized participants with COVID-19, including trial design, endpoints, survival analysis, viral-load analysis, safety, statistical methodology, results, and interpretation.
- OARS-PilotIndependent statistical analysis of Opioid Analgesic Reduction Study (OARS) - Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05283499).
- OASISIndependent statistical analysis of Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- OASIS 2Independent statistical analysis of Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity: primary endpoint results, effect estimate…
- OASIS-1Independent statistical analysis of A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal…
- OASIS-4Independent statistical analysis of A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy…
- OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE): Complete Statistical AnalysisIndependent statistical analysis of OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE): primary endpoint results, effect estimate with confidence…
- OASIS(CM)Independent statistical analysis of Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OATIndependent statistical analysis of Oral Anticoagulation Therapy Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01959425).